More articles from Commentary

  • The underappreciated role of documentation in improving COPD care
    Solmaz Ehteshami-Afshar, MD, MSc and Naseema Merchant, MD
    Cleveland Clinic Journal of Medicine May 2022, 89 (5) 249-251; DOI: https://doi.org/10.3949/ccjm.89a.21044

    Despite the importance of providing guideline-concordant care, there are still barriers to implementing evidence-based recommendations in providing care for patients with chronic obstructive pulmonary disease.

  • Peyronie disease and erectile dysfunction: A potential new paradigm
    Drogo K. Montague, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 661-663; DOI: https://doi.org/10.3949/ccjm.88a.21027

    Viewing Peyronie disease as related to erectile dysfunction allows for the possibility of preventing the disease in patients with erectile insufficiency.

  • SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
    CME article
    Enrico G. Ferro, MD, Bertram Pitt, MD and Deepak L. Bhatt, MD, MPH
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 601-606; DOI: https://doi.org/10.3949/ccjm.88a.21045

    SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.

  • Another influenza season in the shadow of the COVID-19 pandemic
    Another influenza season in the shadow of the COVID-19 pandemic
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 594-597; DOI: https://doi.org/10.3949/ccjm.88a.21095

    Flu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.

  • Teriparatide: Label changes and identifying patients for long-term use
    Paul D. Miller, MD, HDSc (HON), E. Michael Lewiecki, MD, Kelly Krohn, MD and Elliott Schwartz, MD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 489-493; DOI: https://doi.org/10.3949/ccjm.88a.21011

    The changes leave clinicians with the challenge of identifying appropriate patients.

  • Statin intolerance and new lipid-lowering treatments
    Oltion Mesi, MD, Charlie Lin, MD, Haitham Ahmed, MD, MPH and Leslie S. Cho, MD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 381-387; DOI: https://doi.org/10.3949/ccjm.88a.20165

    The benefits and safety of statin therapy are clear, but adverse effects continue to pose diagnostic and therapeutic challenges.

  • What is causing the ‘long-hauler’ phenomenon after COVID-19?
    Leonard H. Sigal, MD, FACP, FACR, MACR
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 273-278; DOI: https://doi.org/10.3949/ccjm.88a.21009

    We are still early in our understanding of COVID-19 and its many manifestations.

  • Our evolving understanding of primary aldosteronism
    Ali Mehdi, MD, MEd, FACP, Pratibha Rao, MD, MPH and George Thomas, MD
    Cleveland Clinic Journal of Medicine April 2021, 88 (4) 221-227; DOI: https://doi.org/10.3949/ccjm.88a.20166

    Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.

  • Cleveland Clinic Journal of Medicine: Evolution and a look ahead
    James S. Taylor, MD, FAAD
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 11-13; DOI: https://doi.org/10.3949/ccjm.88a.20187

    Cleveland Clinic is 100 years old and has had a medical journal for 90 of those years.

  • COVID-19 diagnostic testing and the psychology of precautions fatigue
    Gregory W. Ruhnke, MD, MS, MPH
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 19-21; DOI: https://doi.org/10.3949/ccjm.88a.20086

    Overuse of special precautions can lead to diminished vigilance.

Pages